Italy to be first EU country to produce Russian Sputnik V vaccine

Source : 112 Ukraine

It is planned that Italy will produce 10 million doses of the vaccine until the end of the year
10:48, 9 March 2021

Sputnik V coronavirus vaccine

The Russian Direct Investment Fund (RDIF) has signed the agreement with Swiss Biopharmaceutical Adienne Company on the production of Sputnik V vaccine against Covid-19 in Italy, as Reuters reported.

Italy plans to produce the vaccine at two plants in Lombardy and Central Italy. It is ready to provide 10 million doses from July 2021 until January 2022.

Related: Over 304 million coronavirus vaccinations have already been made in the world

The Italian-Russian chamber of commerce stated that as soon as the Russian vaccine is approved by the European Medicines Agency (EMA), it will be spread all over Italy.

“The Russian authorities work on over 20 joint projects in Europe; Sputnik V vaccine is registered in more than 45 world countries,” the Italian-Russian chamber of commerce explained.

Currently, the EU has signed contracts with six European and American producers of the vaccines and agreed on almost 2.6 billion doses for its 450-million population.

Related: Israel does not recognize Ukrainian vaccination with CoviShield

Currently, Sputnik V vaccine is registered in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran, Guinea, Tunisia, Armenia, Mexico, Nicaragua, Bosnia and Herzegovina, Ghana, Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon and San Marino.

The vaccination from Covid-19 has begun in Ukraine on February 24. The first person to receive the vaccine was Yevhen Horenko, a resuscitator at the Cherkasy Regional Hospital. The Ukrainians are vaccinated by Indian CoviShield vaccine.


Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more